Galux
Seoul, South Korea
Galux is a pioneering company in protein therapeutics design, offering a unique platform, GaluxDesign, which integrates artificial intelligence with physical principles to revolutionize the development of protein therapeutics. The platform enables de novo antibody design, known for its complexity, with unprecedented accuracy. Galux is dedicated to advancing AI-driven protein design for drug discovery, fostering collaborations with industry leaders to develop next-generation therapies for rare diseases and beyond. The company aims to reshape the future of medicine through innovative protein design technologies.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2020
- Website
- galux.co.kr/
Only accessible to MedStartr community members.
Join nowWhat do you think of Galux?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now